[HTML][HTML] Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders

AB Wulff, CD Nichols, SM Thompson - Neuropharmacology, 2023 - Elsevier
Psychedelic compounds have shown extraordinary potential in treating a wide range of
neuropsychiatric disorders. Psilocybin, for example, has now been shown in several clinical …

Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders

AB Wulff, CD Nichols… - Neuropharmacology, 2023 - digitalscholar.lsuhsc.edu
Psychedelic compounds have shown extraordinary potential in treating a wide range of
neuropsychiatric disorders. Psilocybin, for example, has now been shown in several clinical …

Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders

AB Wulff, CD Nichols… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Psychedelic compounds have shown extraordinary potential in treating a wide range of
neuropsychiatric disorders. Psilocybin, for example, has now been shown in several clinical …

Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.

AB Wulff, CD Nichols, SM Thompson - Neuropharmacology, 2023 - europepmc.org
Psychedelic compounds have shown extraordinary potential in treating a wide range of
neuropsychiatric disorders. Psilocybin, for example, has now been shown in several clinical …